Concepts (85)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| alpha 1-Antitrypsin Deficiency | 6 | 2022 | 37 | 1.790 |
Why?
|
| Bile Ducts | 2 | 2012 | 53 | 0.740 |
Why?
|
| Liver Cirrhosis | 4 | 2022 | 832 | 0.600 |
Why?
|
| alpha 1-Antitrypsin | 2 | 2019 | 83 | 0.600 |
Why?
|
| Liver Diseases | 2 | 2015 | 366 | 0.600 |
Why?
|
| Inpatients | 1 | 2022 | 495 | 0.570 |
Why?
|
| Hospitalization | 1 | 2022 | 1777 | 0.420 |
Why?
|
| Autophagy | 3 | 2019 | 394 | 0.410 |
Why?
|
| Cilia | 1 | 2012 | 74 | 0.370 |
Why?
|
| Mesoderm | 1 | 2011 | 110 | 0.360 |
Why?
|
| Cell Transdifferentiation | 1 | 2011 | 65 | 0.350 |
Why?
|
| Cell Lineage | 2 | 2011 | 343 | 0.340 |
Why?
|
| Genetic Therapy | 1 | 2014 | 687 | 0.330 |
Why?
|
| Biliary Atresia | 1 | 2012 | 190 | 0.310 |
Why?
|
| Polycystic Kidney, Autosomal Recessive | 1 | 2008 | 9 | 0.310 |
Why?
|
| Liver Neoplasms | 2 | 2016 | 1314 | 0.310 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 1 | 2008 | 16 | 0.310 |
Why?
|
| Cysts | 1 | 2008 | 101 | 0.290 |
Why?
|
| Liver Transplantation | 1 | 2016 | 1038 | 0.280 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2016 | 931 | 0.280 |
Why?
|
| Epithelial Cells | 1 | 2011 | 909 | 0.260 |
Why?
|
| Liver | 4 | 2022 | 1742 | 0.210 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2022 | 39 | 0.190 |
Why?
|
| MicroRNAs | 1 | 2008 | 838 | 0.190 |
Why?
|
| Abdominal Pain | 1 | 2022 | 308 | 0.160 |
Why?
|
| Glyburide | 1 | 2019 | 23 | 0.160 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2022 | 420 | 0.140 |
Why?
|
| Insulin | 1 | 2022 | 1202 | 0.130 |
Why?
|
| Age Distribution | 1 | 2016 | 417 | 0.120 |
Why?
|
| Cholesterol Ester Storage Disease | 1 | 2014 | 1 | 0.120 |
Why?
|
| Emergency Service, Hospital | 1 | 2022 | 1060 | 0.110 |
Why?
|
| Heterozygote | 1 | 2016 | 671 | 0.110 |
Why?
|
| Alcoholism | 1 | 2016 | 231 | 0.110 |
Why?
|
| Sex Factors | 1 | 2016 | 1287 | 0.100 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 4389 | 0.100 |
Why?
|
| Hepatolenticular Degeneration | 1 | 2012 | 33 | 0.090 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2011 | 48 | 0.090 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2012 | 59 | 0.090 |
Why?
|
| Adolescent | 2 | 2022 | 19316 | 0.090 |
Why?
|
| Humans | 8 | 2022 | 124955 | 0.090 |
Why?
|
| Fibrosis | 1 | 2012 | 433 | 0.080 |
Why?
|
| Age Factors | 1 | 2016 | 2819 | 0.080 |
Why?
|
| Cell Line | 2 | 2019 | 2758 | 0.080 |
Why?
|
| Syndrome | 1 | 2012 | 1121 | 0.080 |
Why?
|
| Child | 2 | 2022 | 24327 | 0.080 |
Why?
|
| Infant | 2 | 2016 | 12455 | 0.080 |
Why?
|
| cdc25 Phosphatases | 1 | 2008 | 21 | 0.080 |
Why?
|
| Cells, Cultured | 2 | 2011 | 3057 | 0.080 |
Why?
|
| Homeostasis | 1 | 2012 | 700 | 0.070 |
Why?
|
| Animals | 6 | 2022 | 34221 | 0.070 |
Why?
|
| Phenotype | 1 | 2016 | 4260 | 0.070 |
Why?
|
| Myocardium | 1 | 2012 | 1019 | 0.070 |
Why?
|
| Stem Cells | 1 | 2011 | 706 | 0.060 |
Why?
|
| Biomarkers | 2 | 2012 | 3084 | 0.060 |
Why?
|
| Mice | 4 | 2022 | 17628 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2022 | 2396 | 0.060 |
Why?
|
| Obesity | 1 | 2016 | 2239 | 0.060 |
Why?
|
| Male | 3 | 2016 | 61419 | 0.060 |
Why?
|
| Female | 3 | 2016 | 66678 | 0.050 |
Why?
|
| Retrospective Studies | 1 | 2022 | 16303 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2011 | 1897 | 0.050 |
Why?
|
| Models, Biological | 1 | 2008 | 1461 | 0.050 |
Why?
|
| Young Adult | 1 | 2016 | 9039 | 0.050 |
Why?
|
| Risk Factors | 1 | 2016 | 10282 | 0.050 |
Why?
|
| Rats | 1 | 2008 | 3728 | 0.050 |
Why?
|
| Mammals | 1 | 2022 | 253 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2016 | 13987 | 0.040 |
Why?
|
| Heart Defects, Congenital | 1 | 2012 | 1817 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2012 | 8192 | 0.040 |
Why?
|
| Aged | 1 | 2016 | 19840 | 0.040 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2019 | 88 | 0.040 |
Why?
|
| Drug Discovery | 1 | 2019 | 171 | 0.040 |
Why?
|
| Caenorhabditis elegans | 1 | 2019 | 223 | 0.030 |
Why?
|
| RNA Interference | 1 | 2019 | 500 | 0.030 |
Why?
|
| Middle Aged | 1 | 2016 | 26900 | 0.030 |
Why?
|
| Adult | 1 | 2016 | 29586 | 0.030 |
Why?
|
| SOX9 Transcription Factor | 1 | 2011 | 80 | 0.020 |
Why?
|
| Integrases | 1 | 2011 | 158 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2022 | 4530 | 0.020 |
Why?
|
| Proteins | 1 | 2014 | 1036 | 0.020 |
Why?
|
| Mutation | 1 | 2022 | 5846 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2011 | 1006 | 0.020 |
Why?
|
| Lung | 1 | 2014 | 1492 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 1708 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2011 | 2309 | 0.010 |
Why?
|